Director, Marketing, Japan

About the role

Reporting to the Executive Director, Head of Commercial Japan, the Director of Marketing Japan will serve as the Japan brand lead for Revolution Medicines' lead molecule for pancreatic cancer and will develop and lead to execute the Japan brand strategy, local go-to-market model and launch readiness plans in preparation for anticipated. You will work within a growing Japan Commercial organization to define the Japan brand strategy and translate insights into a clear, executable brand plan, in close partnership with cross-functional stakeholders across global, regional, and local teams. This position is based in Tokyo, Japan. Responsibilities include: Brand Strategy and Planning Direct the development of the Japan brand strategy and multi-year commercial plans, including annual operating plans and long-range planning inputs for priority assets. Integrate customer, patient, and market insights into actionable strategic recommendations and business decisions. Define the local positioning, value proposition, and messaging strategy in alignment with the global brand strategy and in close partnership with Japan Medical Affairs. Oversee insight-generation plans across disease states, customer segments, and treatment paradigms, leveraging market research, competitive intelligence, and patient journey analyses. Partner with Medical Affairs to provide commercial perspectives on evidence generation, publication planning, and congress strategy. Launch Readiness and Execution Lead critical aspects of Japan launch readiness, including launch planning, milestone management, risk assessment, and mitigation strategies to ensure successful and timely commercialization. Partner with Market Access to ensure brand strategies reflect pricing, reimbursement, and access considerations, including development of payer value propositions and evidence-generation plans (e.g., HEOR and RWE). Lead diagnostic and patient identification strategies for biomarker-driven oncology products, including alignment with companion diagnostic plans, testing pathways, and stakeholder education efforts. Oversee develop and execute tactical marketing plans leveraging global brand assets, including brand narratives, core claims, visual identity, disease awareness initiatives, healthcare professional (HCP) education programs, patient support initiatives, and digital engagement strategies. Manage agency and vendor partnerships, including scope development, performance management, budget oversight, and delivery of high-quality outputs. Lead cross-functional marketing governance with Regulatory, Legal, Compliance, Commercial Operations, and other cross-functional partners to support launch planning and execution and ensure compliant operational readiness. Performance Management and Governance Own the Japan marketing budget, including annual planning, forecasting, spend management, and compliance with company policies. Define and monitor key performance indicators (KPIs), including brand awareness, adoption drivers, HCP engagement, customer behavior, and digital performance metrics where applicable. Partner with Global Analytics and Insights to develop performance dashboards and generate actionable business insights. Ensure all marketing activities comply with applicable regulatory requirements, industry standards, and company policies while fostering a culture of integrity and patient-centric decision-making across internal and external stakeholders. Additional Responsibilities Build, lead, coach, and develop a high-performing Japan marketing team as the organization grows. Partner with Human Resources and Commercial leadership on talent acquisition, succession planning, and organizational design to support business growth and launch readiness. Establish clear objectives, performance expectations, and development plans for direct reports. Required Skills, Experience and Education: Bachelor's degree required; advanced degree (MBA, PhD, PharmD, or equivalent) preferred. Minimum of 10 years of progressive pharmaceutical and/or biotechnology commercial experience, including significant marketing leadership responsibilities required. Proven product launch experience with di

Benefits

Additional Information

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at revolutionmedicines? Share your experience